Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
epilepsy
3
×
biotech
blackstone group
boston
boston blog main
boston top stories
clinical trials
david goldstein
depression
essential tremor
kiran reddy
life sciences
major depressive disorder
national blog main
national top stories
new york blog main
new york top stories
perimenopausal depression
praxis precision medicines
steven petrou
aligos therapeutics
antisense oligonucleotide
baker brothers life sciences
benzodiazepine
benzodiazepines
bigdata
biogen
biotech ipos
blackstone life sciences
blepharitis
cavion
cephalgia
chronic hepatitis b virus
columbia university
demodex blepharitis
epi4k
eventide asset management
fda
hepatitis b
horowitz group
What
precision
3
×
drugs
medicines
praxis
research
academic
aims
backed
biotechs
cause
central
ceo
clinical
cns
disorder
dreaming
emerged
epilepsy
genes
genetic
ipos
kept
leads
links
marcio
medicine
mutations
nervous
neuro
new
prep
quiet
reality
souza
stealth
stop
turn
way
Language
unset
Current search:
epilepsy
×
precision
×
@EpilepsiaJourn
3 years ago
Precision Medicine: Academic dreaming or clinical reality? https://onlinelibrary.wiley.com/doi/abs/10.1111/epi.16739#.X7VgtmsBrDk.twitter #epilepsy #BigData #MachineLearning @IlaeWeb @wileyneurosci https://t.co/0scEwzBsyb
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
